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ModelThe U.S. EPA's SHEDS-Multimedia model was applied to enhance the understanding of children's exposures and
doses to multiple pyrethroid pesticides, including major contributing chemicals and pathways. This paper pre-
sents combined dietary and residential exposure estimates and cumulative doses for seven commonly used py-
rethroids, and comparisons of model evaluation results with NHANES biomarker data for 3-PBA and DCCA
metabolites. Model input distributions were ﬁt to publicly available pesticide usage survey data, NHANES, and
other studies, then SHEDS-Multimedia was applied to estimate total pyrethroid exposures and doses for 3–
5 year olds for one year variability simulations. For dose estimations we used a pharmacokinetic model and
two approaches for simulating dermal absorption. SHEDS-Multimedia predictions compared well to NHANES
biomarker data: ratios of 3-PBA observed data to SHEDS-Multimedia modeled results were 0.88, 0.51, 0.54 and
1.02 for mean, median, 95th, and 99th percentiles, respectively; for DCCA, the ratios were 0.82, 0.53, 0.56, and
0.94. Modeled time-averaged cumulative absorbed dose of the seven pyrethroids was 3.1 nmol/day (versus
8.4 nmol/day for adults) in the general population (residential pyrethroid use and non-use homes) and
6.7 nmol/day (versus 10.5 nmol/day for adults) in the simulated residential pyrethroid use population. For the
general population, contributions to modeled cumulative dose by chemical were permethrin (60%),
cypermethrin (22%), and cyﬂuthrin (16%); for residential use homes, contributions were cypermethrin (49%),
permethrin (29%), and cyﬂuthrin (17%). The primary exposure route for 3–5 year olds in the simulated residen-
tial use population was non-dietary ingestion exposure; whereas for the simulated general population, dietary
exposure was the primary exposure route. Below the 95th percentile, the major exposure pathway was dietary
for the general population; non-dietary ingestion was the major pathway starting below the 70th percentile
for the residential use population. The new dermal absorption methodology considering surface loading had
some impact, but did not change the order of key pathways.
Published by Elsevier Ltd.1. Introduction
Reliable human exposure models are critical for understanding
human health risks from chemicals. TheU.S. EPA has developed, reﬁned,
applied, and evaluated the probabilistic SHEDS-Multimedia model to
improve estimates of human exposure to multimedia, multipathway
chemicals to support both aggregate and cumulative assessments
(Zartarian et al., 2012, 2006; Xue et al., 2010a, 2006; http://www.epa.
gov/heasd/research/sheds/). SHEDS-Multimedia is a physically-based
(simulates human contact with chemicals), probabilistic model that
can simulate aggregate or cumulative exposures over time via dietary
and residential routes of exposure for a variety of multimedia,
multipathway environmental chemicals. SHEDS-Multimedia can be
linked with physiologically-based pharmacokinetic (PBPK) models tocharacterize variability and uncertainty in risk assessments. It is impor-
tant to evaluate model estimates with available biomarker data.
Pyrethroids are the latest class of insecticides in global use and are
replacing organophosphates in agricultural and consumer applications
(Nishi et al., 2006). Pyrethroids are used in agricultural, forest, textile,
and public health programs worldwide (Heudorf and Angerer, 2001).
With the passage of the Food Quality Protection Act of 1996 (FQPA),
EPA is required to consider available information concerning the cumu-
lative effects on human health resulting from exposure to multiple
chemicals that have a commonmechanism of toxicitywhenmaking de-
cisions related to pesticide tolerances (EPA OPP, 2011). In their review
of 22 rodent studies, Shafer et al. (2005) reported that pyrethroids
exert their neurotoxicity by slowing the opening and closing of
voltage-gated sodium channels in insect and mammalian nerve cells
and associations between in utero exposures and persistent changes
in neurochemistry, motor activity, behavior, and learning.
Zartarian et al. (2012) previously published a SHEDS-Multimedia ag-
gregate exposure and dose assessment for a single pyrethroid pesticide,
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throid insecticide, was selected for the previous aggregate SHEDS-
Multimedia model application in Zartarian et al. (2012) because it is
the most commonly used pyrethroid pesticide and the ﬁrst pyrethroid
reviewed under FQPA. This paper extends that research, applying
SHEDS-Multimedia to a cumulative seven pyrethroids case study (per-
methrin, cypermethrin, cyﬂuthrin, allethrin, resmethrin, deltamethrin,
and esfenvalerate), including variability analyses for key pathways
and chemicals, and model evaluation results. To select the seven pyre-
throid pesticides for this case study, we used the 2001–2002 Residential
Exposure Joint Venture (REJV) consumer pesticide product use survey
provided to the U.S. EPA (Jacobs et al., 2003) and NHANES biomarker
data (Barr et al., 2010 Table 1).
To our knowledge, this is the ﬁrst comprehensive cumulative expo-
sure assessment using SHEDS-Multimedia combined with publicly
available datasets. The objectives of this case studywere to: (1) quantify
children's pyrethroid exposures from residential and dietary routes,
identifying major chemicals and pathways; (2) provide reliable input
data and methods for cumulative risk assessment; and (3) evaluate
SHEDS-Multimedia using NHANES biomarker data.
2. Methods
2.1. SHEDS-Multimedia and scenario
The SHEDS-Multimedia technical manuals describe in detail the
model algorithms, methodologies, and input and output capabilities
(Glen et al., 2010; Xue et al., 2010b). SHEDS-Multimedia is comprised
of both a residential module (SHEDS-Residential version 4.0; Glen
et al., 2010; Isaacs et al., 2010a; Zartarian et al., 2008), and a dietary
module (SHEDS-Dietary version 1.0; Xue et al., 2012, 2010a,b; Isaacs
et al., 2010b) linked by a methodology illustrated in Fig. 1. This case
study quantiﬁes population cumulative exposures for 3–5 year olds
(one of the EPA recommended age groups in U.S. EPA, 2005) from
both dietary ingestion and nine residential application scenarios of
seven pyrethroids.
The seven pyrethroids were selected based on residential usage pat-
terns and degradation to the common metabolites, 3-PBA and DCCA
(Barr et al., 2010). For thismultiple pyrethroids case study, nine residen-
tial exposure scenarios were selected based on analyses of the REJV data
(Jacobs et al., 2003), including indoor crack and crevice (aerosol and liq-
uid), indoor ﬂying insect killer (aerosol), indoor fogger (broadcast),
lawn (granular – push spreader and liquid – hand wand), pet treatment
(liquid and spot-on), and vegetable garden (dust, powder). Model input
values for chemical-speciﬁc and non-speciﬁc data inputs for these seven
pyrethroids were mined from peer-reviewed publications, OPP's Resi-
dential Exposure Standard Operating Procedures (U.S. EPA, 2012), rec-
ommendations by OPP's FIFRA SAP, EPA's Exposure Factors Handbook
and Child-Speciﬁc Exposure Factors Handbook (U.S. EPA, 1997, 2008),
and best Agency-derived estimates (http://www.regulations.gov/#!
documentDetail;D=EPA-HQ-OPP-2010-0383-0015).Table 1
Cumulative annual absorbed dose of 7 pyrethroids from residential & dietary sources.
Age group Use population n Mean Std
Adult General population 4143 8.4 9.6
Residential use 815 10.5 11.5
3–5 years old General population 5733 3.1 5.8
Residential use 1101 6.7 10.8
Adult General population 4143 0.13 0.16
Residential use 815 0.17 0.21
3–5 years old General population 5733 0.18 0.34
Residential use 1101 0.39 0.62A multi-chemical approach considering model variance and co-
variance structure and co-occurrence of chemicals is described in the
SHEDS-Multimedia technical manual. Data from the U.S. Department
of Agriculture was used to identify those raw agricultural commodities
where detection limit substitutions were needed (http://www.nass.
usda.gov/Statistics_by_Subject/index.php?sector=CROPS).
The Diversity and Autocorrelation (D & A)method (Glen et al., 2008)
was used to construct longitudinal data for the residential and dietary ex-
posure estimates. Indoor awake timewas set as a key variable for the res-
idential exposure estimates, with D and A statistics set to 0.25 and 0.4,
respectively. Total caloric consumption was used as the key variable for
the dietary exposure estimates, with D and A statistics set to 0.3 and
0.1, respectively (based on longitudinal data from Lu et al., 2006). The cu-
mulative exposure for one year was simulated and statistics for 21 days
were matched with NHANES biomarker data for model evaluation.
2.2. Linkage of dietary and residential exposure modeling
To combine the dietary and residential module outputs we used the
methodology described in Zartarian et al. (2012) and depicted in Fig. 1.
This approach has been previously externally peer-reviewed (FIFRA
SAP, 2007, 2010) and also evaluated in the Zartarian et al., 2012 per-
methrin case study. Here we brieﬂy describe the procedure: 1) Assem-
ble longitudinal data from cross-sectional data for both residential and
dietary using the D & A method; 2) form bins with key variables such
as age and gender; and 3) create 5 small bins from each bin formed by
key variables by percentile range by total caloric consumptionweighted
by bodyweight for dietary and averagedMETweighted by bodyweight
for residential.
2.3. Model application with pyrethroids case study
The SHEDS-Multimedia residential and dietary modules were each
applied to estimate exposures for 3–5 year olds. We generated and an-
alyzed population variability results for annual averaging time to iden-
tify key chemicals and pathways.
2.3.1. Dose estimation
The built-in pharmacokinetic (PK)model to estimate absorbed dose
(Glen et al., 2010) was used for the initial exposure pathway contribu-
tion analysis. A sample size of ~4000 individuals was used for the one
year variability simulations. Results are reported for an annual averag-
ing time and for separate and aggregated pathways.
2.3.2. Dermal absorption adjustment methodology
Skin surface loadings in human dermal studies are typically several
orders of magnitude higher than real-world levels. When surface load-
ing exceeds a uniform monolayer over the course of study, dermal ab-
sorption is ﬂux-limited, yet when surface loading is sparse, as happens
in real-world scenarios, absorption transitions to a supply-limited
state (Kissel, 2011). Thus, when fractional absorption is determinedp5 p25 p50 p75 p95 p99
nmol/day
1.0 2.9 5.7 10.4 24.7 47.0
1.3 4.0 7.2 12.7 31.3 60.1
0.4 0.8 1.4 2.8 12.4 27.0
0.5 1.1 2.3 7.7 26.4 46.3
nmol/kg/day
0.02 0.05 0.09 0.16 0.39 0.79
0.02 0.06 0.11 0.20 0.50 1.04
0.02 0.05 0.09 0.16 0.75 1.64
0.03 0.07 0.14 0.45 1.60 3.04
Fig. 1. Linkage of dietary and residential modules.
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fractional absorption, ultimately biasing the modeled dermal contribu-
tion. Kissel (2011) noted there is often an inverse relationship between
fractional absorption and surface loading in these studies. This sug-
gested to the authors of this paper that a quantitative correction was
feasible, if this condition of inverse proportionality was met.
Indeed, we observed an inverse relationship between fractional ab-
sorption and pyrethroid surface loading [fractional absorption (%) =
−0.432 ln(μg/cm2)+ 2.73; R2= 0.97, N=3] in the dermal dose-excre-
tion studies of (a) Eadsforth et al. (1988), (b) Woollen et al. (1992), and
(c) Tomalik-Scharte et al. (2005). Study “a” applied 25 mg of
cypermethrin in a skin area of 50 cm2 (500 μg/cm2). Study “b” applied
31 mg of cypermethrin in a skin area of 800 cm2 (38.75 μg/cm2). Study
“c” applied 3000 mg of permethrin in a skin area of 19,996 cm2
(150 μg/cm2). The prior SHEDS-Multimedia model case study for per-
methrin used a fractional absorption based on study “c”. Here, amultipli-
er was used to correct fractional absorption by taking the ratio of two
equations, one implementedwith 150 μg/cm2, and the other implement-
ed with the pyrethroid loading under consideration. For instance, a sim-
ulated loading of 0.5 μg/cm2 of pyrethroid would apply a multiplier of
4.96, whereas a loading of 1 × 10−6 μg/cm2 would apply a multiplier of
14.1. In thisway, the dermal absorption ratewas adjusted by skin surface
loading for the SHEDS-Multimedia pyrethroids case study.
2.3.3. Cumulative exposure and dose estimation
To calculate cumulative exposure, we used both a molar method
(Tulve et al., 2011) for model evaluation, and a Relative Potency Factor
(RPF) method (EPA OPP, 2011) that accounts for toxicity. For the
molar method, each pyrethroid was divided by its molecular weight to
convert estimated dose into mole units, and results for the seven pyre-
throids were summed to obtain total pyrethroids inmoles. According to
data provided by EPA/OPP (EPA OPP, 2011), deltamethrin was
established as the index chemical with an RPF of 1 and the other six py-
rethroids were normalized by it. Then the cumulative exposures of the
seven pyrethroids were added to obtain the total exposure.
2.3.4. SHEDS-Multimedia model evaluation against biomarker data
For the model evaluation, cumulative modeled SHEDS-PK dose
predictions were compared to NHANES biomonitoring data for theurinary metabolites, cis- and trans-3-(2,2-dichlorovinyl)-2,2-
dimethylcyclopropane-1-carboxylic acid (cis- and trans-DCCA) and
3-phenoxybenzoic acid (3-PBA) (DCCA and 3-PBA are non-speciﬁc
metabolites for a number of pyrethroid pesticides).
3. Results
3.1. Pyrethroids population dose and contributions by chemical and pathway
Summary statistics (in nmol) for the total (aggregated across dietary
and residential pathways) annual averaged absorbed dose pyrethroid
population estimates for the different simulated populations are
shown in Table 1. Mean and 50th, 95th, and 99th percentiles of the
modeled dose for 3–5 year olds are 3.1, 1.4, 12.4, and 27.0 nmol/day
for the simulated general population and 6.7, 2.3, 26.4, and 46.3 for
the simulated residential pyrethroid use population, respectively. The
cumulative exposure of the residential use population is higher than
the general population. Adult absolute values were higher, as shown
in the table; if weight-adjusted, children have a higher dose per body
weight than adults.
Analyses were conducted for the relative contribution to total
absorbed dose by each of the included pyrethroid chemicals and
SHEDS-Multimedia exposure routes for 3–5 year old children, consider-
ing the general population and residential use population. Themajor ex-
posure pathway for the general population, based on means, was
dietary ingestion (72% and 61%, based on the molar and RPF methods,
respectively) followed by non-dietary ingestion (23% and 32%, based
on the molar and RPF methods, respectively), dermal (5% and 6%,
based on the molar and RPF methods, respectively), and inhalation
(0% and 1%, based on the molar and RPF methods, respectively) (see
Fig. 2a and b). For residential use population, non-dietary ingestion
was the key exposure pathway (55% and 64%, based on the molar and
RPF methods, respectively), followed by dietary (32% and 23%, based
on the molar and RPF methods, respectively), dermal (12% with both
methods), and inhalation (1% with both methods) (see Fig. 2c and d).
These results incorporate the new dermal exposure methodology:
surface loading issues have some impact, but do not change the order
of key pathways. Contributions from the dermal pathway are 5% and
12% for residential use and general population, respectively, with the
Fig. 2. Contribution of 7 cumulative pyrethroids absorbed dose based on means by pathway for 3–5 years olds.
307J. Xue et al. / Environment International 73 (2014) 304–311adjusted multiplier, and 4% and 9% without (based on the mole
method).
Fig. 3 shows the box-and-whisker plots comparing modeled py-
rethroids dose estimates by pathways and individual pyrethroid,
for the residential use scenario, and for the entire distribution (rath-
er than means only as in Fig. 2). From Fig. 3a (molar method), per-
methrin has the highest contribution followed by cyﬂuthrin, but
cypermethrin and allethrin have higher variances. From Fig. 3b
(RPF method), cyﬂuthrin has the highest contribution followed by
permethrin, with higher variances for cypermethrin and allethrin.
The dietary pathway has the highest contribution, and the inhala-
tion pathway has the highest variance (Fig. 3c with molar method
and 3d with RPF method).Fig. 3. Box-and-whisker plots comparing pyrethroids exposure bFor lower percentiles, Fig. 4 shows that the primary exposure route
for simulated 3–5 year olds is dietary. Fig. 4a shows that for the general
population, the dietary route is the major contributor for the total
absorbed dose of seven pyrethroids up to the ~95th percentile, and
above the ~95th percentile, non-dietary ingestion is the dominant expo-
sure route. Fig. 4b shows that for residential use households, absorbed
dose for the seven pyrethroids is greater than in the general population.
For the residential use population, non-dietary ingestion is the major
pathway above the ~70th percentile; below that, dietary is predominant.
Supplemental Figs. 1 and 2 (S-1 and S-2) further illustrate that the
two major routes are dietary and non-dietary. The contribution from
these 2 routes is comparable between the 90th and 100th percentiles
for the general population of 3–5 year olds; the dermal route hasy pathway and individual pyrethroids (residential use only).
Fig. 4. CDF of cumulative absorbed dose for 7 pyrethroids by pathway for 3–5 year olds.
Fig. 5. Contribution of cumulative absorbed dose based on means by 7 major pyrethroids for 3–5 year olds.
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309J. Xue et al. / Environment International 73 (2014) 304–311some effect above the 90th percentile (S-1). For the residential use pop-
ulation, non-dietary dominates at high percentiles and dermal hasmore
importance above the 60th percentile (S-2).
Fig. 5a and c shows that for the general population and using the
molar-based approach, contributions to the cumulative dose by chemi-
cal were permethrin (60%), cypermethrin (22%), cyﬂuthrin (16%); the
order is different for residential use: cypermethrin (49%), permethrin
(29%), and cyﬂuthrin (17%). Fig. 5b and d shows the results using the
RPFmethod.When compared to themolar-based approach, the relative
importance of cyﬂuthrin and deltamethrin increases and that of per-
methrin decreases. Using the RPF approach, contributions to the cumu-
lative dose by chemical for the general population were cyﬂuthrin
(63%), permethrin (17%), cypermethrin (14%), deltamethrin (5%); the
order is different for the residential use scenario: cyﬂuthrin (58%),
cypermethrin (26%), deltamethrin (9%), and permethrin (7%).
3.2. Evaluation of SHEDS-Multimedia modeled permethrin exposure and
dose estimates
Fig. 6 compares SHEDS-Multimedia predicted dose estimates, using
the built-in PK model (and molar-based approach), against NHANES
3-PBA andDCCA biomarker data. For 3-PBA, the ratios of observedmea-
sured 1999–2002 NHANES data over modeled estimates were 0.88,
0.51, 0.54 and 1.02 for mean, median, 95th, and 99th percentiles, re-
spectively; for DCCA, the ratios were 0.82, 0.53, 0.56 and 0.94. Evalua-
tion with 2007–2008 biomarker data from NHANES conﬁrmed these
results (S-3). For both evaluations, the percent relative errors ranged
from 2% to 50% at the 95th and 99th percentiles (average = 22%).
4. Discussion
4.1. Model evaluation
It is important to evaluate or “ground truth” human exposure
models, including modules within them and overall model predictions
using relevant data inputs and exposure and dose scenarios. This is par-
ticularly important for models used in regulatory decision-making. The
SHEDS-Multimedia pyrethroids dose predictions, using a PK model,
comparedwell to NHANES biomarker data formean and higher percen-
tiles; comparisons for lower percentiles were not as good. Matching the
higher percentiles is appropriate for a protective risk assessment, but
consistency for the entire distribution is important for characterizing
the population distribution of risk. We think this model evaluation can
be improved with better characterization of variance and co-variance
structures through assembling longitudinal data from cross-sectional
data (includingmore longitudinal data available in the future), enhanc-
ing the dietary and residential diary merging algorithm, and reﬁning
distributions of many inputs — especially for pyrethroids in variousFig. 6. Radios of urinary biomarker by 1999–2002 NHANES over SHEDS results.media for low percentiles and detection rates. Additional model evalua-
tion using NHANES and measurement study data is underway and
planned for a combined assessment of these seven pyrethroids using
PBPK modeling.
SHEDS-Multimedia has been well evaluated previously for arsenic,
mercury, chlorpyrifos, and permethrin (http://www.epa.gov/heasd/
research/sheds/user_information.html/). In our aggregate permethrin
evaluation (Zartarian et al., 2012), permethrin contribution to DCCA
and 3-PBAmetabolites was ~50%, which is consistent with the 60% con-
tribution of total exposure from permethrin for the general population
in this cumulative pyrethroids analysis (Fig. 5a). This is also consistent
with ﬁndings by Morgan et al.: the mean and 95th percentile for mea-
sured urinary 3-PBA concentrations were 0.9 and 1.9 μg/L, respectively,
and the authors estimated that the aggregate absorbed doses of per-
methrin accounted for about 60% of the excreted amounts of 3-PBA
found in the children's urine (Morgan et al., 2007). We used REJV data
to simulate pyrethroid residential users and non-users; ~16% of pyre-
throid residential usewas simulated per REJV data, which is comparable
with 13% of the participants in CTEPP-Ohio and 14% of the participants
in CTEPP-North Carolina (Morgan et al., 2005).
4.2. SHEDS-Multimedia dose estimates compared to EPA screening
level estimates
In comparison with EPA/OPP's pyrethroids, the relevant values that
can be used for comparison are the 95th and 99th percentiles of dietary
exposure (with the RPF method) for 3–5 year olds 1.68E-4 and 7.1E-
4 mg/kg/day (Table 5.3a from EPA OPP, 2011) versus the 95th and
99th percentiles from SHEDS-Multimedia 4.04E-5 and 6.38E-5. The dif-
ference is comparable, but results from the OPP assessment are higher,
since OPP values are for short-term exposures and the SHEDS-
Multimedia values are annual averages.
4.3. Dermal exposure
The SHEDS-Multimedia modeling of permethrin (Zartarian et al.,
2012), applied a fractional absorption of permethrin based on the dermal
dose-excretion study of Tomalik-Scharte et al. (2005). Herewemodiﬁed
our method according to Kissel (2011), who observed that in ﬂux-
limited systems (i.e., dermal studies conducted with high surface load-
ings) an inverse proportionality between surface loading and fractional
absorption may be observed. We conﬁrmed this observation and used
this relationship to correct the fractional absorption applied by SHEDS
in accordancewith the estimated surface loading. The three dermal stud-
ies informing the correction were conducted with cypermethrin and
permethrin. Here, we assumed that the physicochemical properties of
these chemicals are the driver for dermal ﬂux and reasonably represen-
tative of the other pyrethroids. The percentage of dermal contribution
increased, but the new approach did not change the order by exposure
pathway. Although the newmethod increased the fractional absorption
for lower surface loadings, the impact was offset to a large degree by the
actual lower surface loadings. Important shortcomings of our approach
include: (1) extrapolation of our fractional absorption model to very
low dermal surface loadings; (2) implicit assumption that dermal ﬂux
is comparable in children and adults; and, (3) we do not account for
the effect that the pyrethroid vehicle/matrix may exert in modulating
dermal absorption.
4.4. Contribution of individual pyrethroids to cumulative exposure
and pathway
Dietary exposure is a major pathway for the general population,
whereas non-dietary ingestion exposure has the biggest contribution
for a simulated population of residential pyrethroid insecticide users.
The Lu et al. (2006) longitudinal study of pyrethroid exposure and bio-
markers with conventional and organic diets showed that organic diets
310 J. Xue et al. / Environment International 73 (2014) 304–311did not change substantially the concentration of urinary pyrethroid
biomarkers; the conclusion from that paper was that pyrethroid expo-
sures are mainly from the residential pyrethroid use population. This
is consistent with our ﬁndings of 55% from non-dietary ingestion and
32% from the dietary pathway for the residential use population
(Fig. 2c). Based on variability exposure results, the contribution from
the dietary pathway is much smaller in comparison with other path-
ways: dietary exposure is the baseline exposure, and non-dietary expo-
sure from residential use is the dominant pathway for more highly
exposed populations (see S-2). These SHEDS-Multimedia modeled esti-
mates support the observations published by Tulve et al. (2011).
Using the molar method for the general population, permethrin is
themajor pyrethroid dose contributor. For the simulated residential py-
rethroid use population, the contribution is much lower (~30% as seen
in Fig. 5c), and cypermethrin is the dominant pyrethroid contributor.
However, cyﬂuthrin has the biggest contribution when the RPF method
is used. Our ﬁndings for 3–5 year olds of the general simulated popula-
tion are very close to the CTEPP study ﬁndings that aggregate absorbed
doses of permethrin accounted for ~60% of the excreted amounts of 3-
PBA found in the children's urine (Morgan et al., 2007).4.5. Uncertainty
Uncertainty is inherent in all exposure models and it is important to
characterize the uncertainty in regards to model structure and data
inputs. Currently, there is not enough data for us to characterize the un-
certainty for the seven pyrethroids included in this cumulative assess-
ment. However, our results are estimated using publicly available
large datasets and then the simulated results are evaluated using the
NHANES biomarker data, thereby reducing the uncertainty in the
modeled estimates.5. Conclusions
This paper presents a cumulative exposure and dose assessment
for 3–5 year old children residing in both pyrethroid residential use
and non-use homes, using the SHEDS-Multimedia model. Close com-
parison of model estimates against measured NHANES biomarker
data provided evaluation of the SHEDS-Multimedia algorithms and
approaches used, and more conﬁdence in SHEDS-Multimedia for
use in cumulative exposure assessments. In addition to the evalua-
tion of the SHEDS-Multimedia cumulative assessment methodology
with a seven pyrethroids case study, key contributions of this paper
to the scientiﬁc literature include an application of a new dermal ex-
posure method and analysis against results using a simpler method;
estimates of children's cumulative pyrethroid exposure and dose
levels for seven commonly used pesticides; and estimates of contri-
bution to cumulative dose by chemical and pathway using a molar
method and RPF method, and a large dataset.
Future model sensitivity and uncertainty analyses can help identify
key factors and research needs to inform exposure measurement re-
searchers and environmental health decision-makers. Collecting data
for key inputs will reduce uncertainty for enhancing SHEDS-Multimedia
model predictions in future applications. This data will also be relevant
and applicable to other model research groups.Disclaimer
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